Endogenous tissue renin-angiotensin systems. From molecular biology to therapy.
Expression of the genes for renin and angiotensinogen has been documented in the heart and brain of several species, including rodents and primates. In the same tissues, local generation of angiotensin II has also been demonstrated. Neuropeptidergic brain angiotensin and local cardiac angiotensin participate in cardiovascular regulation. Inhibition of cardiac angiotensin II protects against deleterious arrythmogenic and metabolic effects of transient regional myocardial ischemia, and blockade of brain angiotensin II effectively lowers blood pressure in spontaneously hypertensive rats. It is surmised therefore that the therapeutic effects of converting enzyme inhibitors are, in part, brought about by inhibition of local tissue angiotensin II generation in addition to their interference with the hormonal plasma renin-angiotensin system. This would help to explain their therapeutic efficacy in pathophysiologic conditions in which hypertension is associated with low plasma renin activity.
Jin
M
M
German Institute for High Blood Pressure Research, University of Heidelberg, West Germany.
Wilhelm
M J
MJ
Lang
R E
RE
Unger
T
T
Lindpaintner
K
K
Ganten
D
D
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002216:Captopril / Q000494:pharmacology; D006973:Hypertension / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D012084:Renin-Angiotensin System
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril